LOS ANGELES CAPITAL MANAGEMENT LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$727,838
-18.5%
14,493
+2.5%
0.00%
-25.0%
Q2 2023$893,522
+227.7%
14,138
+133.3%
0.00%
+300.0%
Q1 2023$272,684
+20.6%
6,061
+17.4%
0.00%0.0%
Q4 2022$226,147
-40.5%
5,162
-10.4%
0.00%
-50.0%
Q3 2022$380,000
-77.4%
5,762
-63.4%
0.00%
-66.7%
Q4 2021$1,685,000
+3.1%
15,732
-1.1%
0.01%
-14.3%
Q3 2021$1,635,000
+16.9%
15,9060.0%0.01%
+16.7%
Q2 2021$1,399,000
-25.8%
15,906
-18.0%
0.01%
-33.3%
Q1 2021$1,886,000
-49.0%
19,396
-41.1%
0.01%
-43.8%
Q4 2020$3,695,000
+15.6%
32,951
-4.5%
0.02%
+6.7%
Q3 2020$3,197,000
+0.4%
34,491
-15.5%
0.02%0.0%
Q2 2020$3,185,000
+131.8%
40,827
+73.7%
0.02%
+66.7%
Q1 2020$1,374,000
+0.6%
23,503
+37.8%
0.01%
+28.6%
Q4 2019$1,366,000
-4.7%
17,055
-12.6%
0.01%
-12.5%
Q3 2019$1,434,000
-28.7%
19,515
-8.4%
0.01%
-27.3%
Q2 2019$2,010,000
+40.4%
21,305
+19.1%
0.01%
+37.5%
Q1 2019$1,432,000
+63.3%
17,890
+9.9%
0.01%
+60.0%
Q4 2018$877,000
-49.4%
16,275
-26.7%
0.01%
-44.4%
Q3 2018$1,732,000
+4.0%
22,190
-15.4%
0.01%0.0%
Q2 2018$1,666,000
+202.4%
26,240
+336.6%
0.01%
+200.0%
Q1 2018$551,0006,0100.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders